Skip to content
The Policy VaultThe Policy Vault

Ongentys (opicapone) — Medica

Parkinson’s disease

Initial criteria

  • Patient is currently receiving carbidopa/levodopa therapy
  • Medication is prescribed by or in consultation with a neurologist

Approval duration

1 year